Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.
until further notice
SourceClinical Microbiology and Infection, 10 Suppl 1, 1, (2004), pp. 107-17
Article / Letter to editor
Display more detailsDisplay less details
Blood Transfusion and Transplantation Immunology
Clinical Microbiology and Infection
vol. 10 Suppl 1
SubjectUMCN 1.5: Interventional oncology
Voriconazole is a new antifungal agent that can be given orally and intravenously. It has proven efficacy for treating candidosis and invasive aspergillosis as well as other mould infections, such as those caused by Fusarium and Scedosporium spp. The drug is generally well tolerated.
This item appears in the following Collection(s)
- Academic publications 
- Electronic publications 
- Faculty of Medical Sciences 
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.